| Name | Title | Contact Details |
|---|---|---|
Darren Lensky |
Director, Information Security - Digital Governance, Risk & Compliance | Profile |
Naresh Vurukonda |
Associate Director, Information Systems | Profile |
Scott Skellenger |
Senior Vice President and Chief Information Officer | Profile |
Patrick Zeller |
Chief Privacy Officer and Sr. Cybersecurity | Profile |
David Reese |
Executive Vice President and Chief Technology Officer | Profile |
St. Marys Children's Hospital is a West Palm Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Using our proprietary platform technology, GT Biopharma is generating novel immuno-oncology biopharmaceutical drugs targeting cancers such as acute lymphocytic leukemia, non-Hodgkin`s lymphoma, acute myeloid leukemia and multiple solid tumors by leveraging our proprietary NK cell engager (TriKE™) platform technology.
RxGen is a Hamden, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Inivata is a leader in liquid biopsy. Its InVision® platform unlocks essential genomic information from a simple blood test to transform the care of cancer patients. The Company`s technology is based on pioneering research from the Cancer Research UK Cambridge Institute, University of Cambridge and backed by multiple high calibre publications. Its lead product, InVisionFirst™-Lung, is commercially available and provides molecular insights that enable clinicians to make more informed treatment decisions for NSCLC patients. Inivata is partnering with pharmaceutical and biotechnology companies on InVisionFirst-Lung and its wider platform, which is applicable to a range of cancer types. The Company has a CLIA laboratory in Research Triangle Park, NC and R&D laboratories in Cambridge, UK.
Interpace Biosciences is a company that provides molecular and related first line diagnostic tests for evaluating risk of cancer, as well as specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted...